Gregg Prawdzik

Gregg Prawdzik is currently the Director of Toxicology Operations at BridgeBio and the owner of g.a.p. nonclinical. With extensive experience in nonclinical development and operations, Gregg has held roles including Associate Director of Nonclinical Operations at Sangamo Therapeutics and Senior Manager of Nonclinical Studies at Revance Therapeutics, where responsibilities included managing CROs and overseeing nonclinical safety studies. Previously, Gregg contributed to research at Bayer Pharmaceuticals and Genentech, earning awards for dedication and excellence in research. Additionally, Gregg has a background in culinary arts, having worked as a chef and professional cook prior to transitioning into scientific roles.